Sucampo Pharma (SCMP) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Sucampo Reports Second Quarter 2016 Financial Results
August 3, 2016 6:30 AM EDTResults Driven by 49% Growth in Revenue
Adjusted EPS Growth of 10%
Company Reiterates 2016 Guidance
Company to Host Conference Call Today at 8:30 a.m. ET
ROCKVILLE, Md., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the second quarter ended June 30, 2016.
... More


